Research has shown that care provided through teledermatology is comparable to that delivered in face-to-face appointments, and future dermatologists are being taught to deliver care this way to improve patient access to expert dermatological care, said Nellie Konnikov, MD, professor and chief of dermatology at the Boston Department of Veterans Affairs.
Research has shown that care provided through teledermatology is comparable to that delivered in face-to-face appointments, and future dermatologists are being taught to deliver care this way to improve patient access to expert dermatological care, said Nellie Konnikov, MD, professor and chief of dermatology at the Boston Department of Veterans Affairs (VA).
Transcript (modified)
Is there any research on how the outcomes of teledermatology compare with those of face-to-face appointments?
Over the last 7 to 10 years, there are plenty of publications proving that it is effective methods of delivering dermatologic care ot our veterans. Research came from different VAs; for example, Milwaukee VA and Providence VA, especially, with satisfaction among patients and among doctors very high and comparable to care with face to face dermatology.
How would you like to see teledermatology evolve and improve?
Teledermatology is the part of the armamentarium within the whole healthcare delivery system. Right now we teach future dermatologists, residents in dermatology, to provide this type of care. And I think it will compliment any healthcare system in terms of access to expert dermatological care, and cost effectiveness of it.
What are some of the main barriers to implementing teledermatology?
The barrier could be the acceptance among primary care physicians because it's not how good the advice is, or how correct the diagnosis is, it's only if we have nurse practitioners, physicians assistants, or primary care physicians to follow our management advice, and to follow up with patients with skin disorders.
Surgery, Chemotherapy Considered Protective Survival Factors in Patients With OC, Liver Metastases
May 21st 2024Surgery and chemotherapy significantly improved both overall survival (OS) and cancer-specific survival (CSS) in patients with liver metastases originating from ovarian cancer (OC), who generally face a poor prognosis with a 5-year survival rate of less than 30%.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Certain genes have been linked to significant weight reduction in obesity treatment; research boosts plaintiffs’ cases against Johnson & Johnson for their talc-based baby powder; proposed legislation aims to address concerns following Alabama Supreme Court ruling on embryos.
Read More